Shanghai Runda Medical Technology Future Growth
Future criteria checks 3/6
Shanghai Runda Medical Technology is forecast to grow earnings at 94.6% per annum. EPS is expected to grow by 95.3% per annum.
Key information
94.6%
Earnings growth rate
95.3%
EPS growth rate
| Life Sciences earnings growth | 31.9% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 20 May 2024 |
Recent future growth updates
No updates
Recent updates
Earnings Tell The Story For Shanghai Runda Medical Technology Co., Ltd. (SHSE:603108) As Its Stock Soars 39%
Oct 22
These 4 Measures Indicate That Shanghai Runda Medical Technology (SHSE:603108) Is Using Debt Extensively
Oct 18Shanghai Runda Medical Technology (SHSE:603108) Has A Somewhat Strained Balance Sheet
Jun 26Shanghai Runda Medical Technology Co., Ltd.'s (SHSE:603108) Earnings Haven't Escaped The Attention Of Investors
Jun 04Does Shanghai Runda Medical Technology (SHSE:603108) Deserve A Spot On Your Watchlist?
Mar 21Shanghai Runda Medical Technology Co., Ltd. (SHSE:603108) Stock Rockets 31% But Many Are Still Ignoring The Company
Mar 04These 4 Measures Indicate That Shanghai Runda Medical Technology (SHSE:603108) Is Using Debt Extensively
Feb 27Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2024 | 8,433 | 40 | 455 | 754 | N/A |
| 6/30/2024 | 8,761 | 190 | 513 | 802 | N/A |
| 3/31/2024 | 9,042 | 215 | 525 | 819 | N/A |
| 12/31/2023 | 9,147 | 273 | 410 | 730 | N/A |
| 9/30/2023 | 9,751 | 395 | 191 | 452 | N/A |
| 6/30/2023 | 10,255 | 433 | -411 | -139 | N/A |
| 3/31/2023 | 10,504 | 457 | -499 | -225 | N/A |
| 12/31/2022 | 10,494 | 418 | -701 | -429 | N/A |
| 9/30/2022 | 9,854 | 365 | -577 | -266 | N/A |
| 6/30/2022 | 9,378 | 336 | -172 | 155 | N/A |
| 3/31/2022 | 9,008 | 332 | -61 | 240 | N/A |
| 12/31/2021 | 8,860 | 380 | 70 | 371 | N/A |
| 9/30/2021 | 8,784 | 416 | -236 | 122 | N/A |
| 6/30/2021 | 8,369 | 422 | -123 | 244 | N/A |
| 3/31/2021 | 7,790 | 388 | 34 | 398 | N/A |
| 12/31/2020 | 7,069 | 330 | -8 | 323 | N/A |
| 9/30/2020 | 6,784 | 253 | -23 | 249 | N/A |
| 6/30/2020 | 6,700 | 246 | -86 | 162 | N/A |
| 3/31/2020 | 6,820 | 273 | -333 | -61 | N/A |
| 12/31/2019 | 7,052 | 310 | -42 | 247 | N/A |
| 9/30/2019 | 6,821 | 311 | 170 | 452 | N/A |
| 6/30/2019 | 6,464 | 292 | 204 | 481 | N/A |
| 3/31/2019 | 6,200 | 273 | 323 | 574 | N/A |
| 12/31/2018 | 5,964 | 262 | 274 | 539 | N/A |
| 9/30/2018 | 5,729 | 295 | 38 | 288 | N/A |
| 6/30/2018 | 5,351 | 267 | N/A | 167 | N/A |
| 3/31/2018 | 4,855 | 242 | N/A | -6 | N/A |
| 12/31/2017 | 4,319 | 219 | N/A | -88 | N/A |
| 9/30/2017 | 3,642 | 199 | N/A | -169 | N/A |
| 6/30/2017 | 3,029 | 164 | N/A | -152 | N/A |
| 3/31/2017 | 2,516 | 134 | N/A | -171 | N/A |
| 12/31/2016 | 2,165 | 116 | N/A | -125 | N/A |
| 9/30/2016 | 1,948 | 115 | N/A | -96 | N/A |
| 6/30/2016 | 1,812 | 105 | N/A | -228 | N/A |
| 3/31/2016 | 1,721 | 95 | N/A | -205 | N/A |
| 12/31/2015 | 1,629 | 92 | N/A | -227 | N/A |
| 9/30/2015 | 1,528 | 92 | N/A | -101 | N/A |
| 6/30/2015 | 1,483 | 84 | N/A | -22 | N/A |
| 3/31/2015 | 1,420 | 81 | N/A | 112 | N/A |
| 12/31/2014 | 1,359 | 75 | N/A | 36 | N/A |
| 12/31/2013 | 1,026 | 68 | N/A | 32 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 603108's forecast earnings growth (94.6% per year) is above the savings rate (2.8%).
Earnings vs Market: 603108's earnings (94.6% per year) are forecast to grow faster than the CN market (26.3% per year).
High Growth Earnings: 603108's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 603108's revenue is forecast to grow faster than the CN market.
High Growth Revenue: Insufficient data to determine if 603108's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 603108's Return on Equity is forecast to be high in 3 years time